Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib + Ketogenic Diet in FL and EC
NCT04750941Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of copanlisib in follicular lymphoma (FL), endometrial cancer (EC), sponsored by Columbia University. Started Feb 2022; status: terminated.
02
Drugs
copanlisib
03
Conditions
follicular lymphoma (FL)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT04750941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750941.